Wells Fargo & Company MN increased its position in shares of Amdocs Ltd. (NASDAQ:DOX) by 26.9% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 2,198,285 shares of the company’s stock after buying an additional 466,314 shares during the period. Wells Fargo & Company MN’s holdings in Amdocs were worth $127,170,000 as of its most recent filing with the SEC.
Other large investors also recently made changes to their positions in the company. Capital Fund Management S.A. boosted its stake in Amdocs by 139.8% in the second quarter. Capital Fund Management S.A. now owns 211,494 shares of the company’s stock valued at $12,207,000 after buying an additional 123,308 shares during the period. PGGM Investments boosted its stake in Amdocs by 3.6% in the second quarter. PGGM Investments now owns 743,332 shares of the company’s stock valued at $42,905,000 after buying an additional 25,653 shares during the period. Noesis Capital Mangement Corp raised its position in shares of Amdocs by 0.3% in the second quarter. Noesis Capital Mangement Corp now owns 131,315 shares of the company’s stock valued at $7,580,000 after buying an additional 415 shares during the period. Capstone Asset Management Co. raised its position in shares of Amdocs by 1.3% in the third quarter. Capstone Asset Management Co. now owns 46,357 shares of the company’s stock valued at $2,682,000 after buying an additional 578 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. purchased a new position in shares of Amdocs during the second quarter valued at $34,749,000. Hedge funds and other institutional investors own 89.18% of the company’s stock.
Shares of Amdocs Ltd. (NASDAQ:DOX) opened at 59.26 on Thursday. The stock has a market capitalization of $8.70 billion, a price-to-earnings ratio of 21.88 and a beta of 0.64. Amdocs Ltd. has a 12 month low of $50.06 and a 12 month high of $61.33. The stock’s 50 day moving average price is $59.12 and its 200-day moving average price is $58.94.
Amdocs (NASDAQ:DOX) last posted its quarterly earnings data on Tuesday, November 8th. The company reported $0.89 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.00. Amdocs had a net margin of 11.01% and a return on equity of 14.61%. The firm had revenue of $940.70 million for the quarter, compared to analysts’ expectations of $941.19 million. During the same period in the previous year, the company posted $0.84 EPS. The company’s quarterly revenue was up 1.5% compared to the same quarter last year. Equities analysts forecast that Amdocs Ltd. will post $3.79 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Friday, January 13th. Stockholders of record on Friday, December 30th were issued a dividend of $0.195 per share. This represents a $0.78 annualized dividend and a dividend yield of 1.32%. The ex-dividend date was Wednesday, December 28th. Amdocs’s dividend payout ratio is currently 28.78%.
Several research analysts recently weighed in on DOX shares. Oppenheimer Holdings Inc. reaffirmed an “outperform” rating and issued a $65.00 target price on shares of Amdocs in a research report on Monday, October 24th. Bank of America Corp. reissued a “buy” rating and issued a $63.00 price objective on shares of Amdocs in a research report on Wednesday, November 9th. Finally, Zacks Investment Research lowered Amdocs from a “hold” rating to a “sell” rating in a research report on Tuesday, January 10th. One analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $63.33.
Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Ltd. (NASDAQ:DOX).